We are live on ! Find out more
PDLI

PDL BioPharma, Inc.
PDLI

Delisted

PDLI was delisted on the 30th of December, 2020.

Back to rankings

186 hedge funds and large institutions have $466M invested in PDL BioPharma, Inc. in 2017 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 63 increasing their positions, 44 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

138% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 13

45% more capital invested

Capital invested by funds: $321M → $466M (+$145M)

43% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 44

9% more funds holding

Funds holding: 171 → 186 (+15)

37% less call options, than puts

Call options by funds: $450K | Put options by funds: $717K

Holders
186
Holders Change
+15
Holders Change %
+8.77%
% of All Funds
4.64%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
31
Increased
63
Reduced
44
Closed
13
Calls
$450K
Puts
$717K
Net Calls
-$267K
Net Calls Change
-$555K

Top Buyers

1
Millennium Management
Millennium Management
New York
+$8.55M
2
Morgan Stanley
Morgan Stanley
New York
+$6.49M
3
State Street
State Street
Massachusetts
+$5.81M
4
Mackenzie Financial
Mackenzie Financial
Ontario, Canada
+$3.96M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$3.56M

Top Sellers

1
Citadel Advisors
Citadel Advisors
Florida
-$9.56M
2
Bank of America
Bank of America
North Carolina
-$4.6M
3
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board
Ontario, Canada
-$3.61M
4
BlackRock
BlackRock
New York
-$2.18M
5
Deutsche Bank
Deutsche Bank
Germany
-$2M
Name Holding Trade Value Shares
Change 		Change in
Stake
State Board of Administration of Florida Retirement System
76
State Board of Administration of Florida Retirement System
Florida
$479K – – –
UBS AM
77
UBS AM
Illinois
$467K – – –
HCM
78
Highbridge Capital Management
New York
$449K +$313K +112,477 +562%
State of New Jersey Common Pension Fund D
79
State of New Jersey Common Pension Fund D
New Jersey
$424K – – –
Manulife (Manufacturers Life Insurance)
80
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$422K -$17K -6,120 -5%
State of Wisconsin Investment Board
81
State of Wisconsin Investment Board
Wisconsin
$414K – – –
AAM
82
Advisors Asset Management
Colorado
$397K -$138K -49,669 -30%
MLICM
83
Metropolitan Life Insurance Company (MetLife)
New York
$389K -$4.26K -1,533 -1%
KBC Group
84
KBC Group
Belgium
$387K +$239K +86,071 +306%
ZCM
85
Zebra Capital Management
Connecticut
$372K -$16.3K -5,865 -5%
AIG
86
American International Group
New York
$361K +$22.2K +7,972 +8%
OAM
87
Oxford Asset Management
United Kingdom
$359K +$295K +106,046 New
NCCM
88
Nine Chapters Capital Management
New Jersey
$358K +$189K +68,100 +182%
Principal Financial Group
89
Principal Financial Group
Iowa
$348K -$11.9K -4,272 -4%
ProShare Advisors
90
ProShare Advisors
Maryland
$335K +$2.64K +950 +1%
NFA
91
Nationwide Fund Advisors
Ohio
$323K -$41K -14,732 -13%
LPL Financial
92
LPL Financial
California
$318K -$6.13K -2,205 -2%
VOYA Investment Management
93
VOYA Investment Management
Georgia
$280K – – –
Citigroup
94
Citigroup
New York
$280K +$228K +81,986 +13,733%
MWNA
95
Marshall Wace North America
New York
$265K +$246K +88,446 New
Susquehanna International Group
96
Susquehanna International Group
Pennsylvania
$261K – – –
GC
97
Guggenheim Capital
Illinois
$234K -$30.7K -11,043 -14%
Ohio Public Employees Retirement System (OPERS)
98
Ohio Public Employees Retirement System (OPERS)
Ohio
$230K +$5.81K +2,091 +3%
PCM
99
Prelude Capital Management
New York
$228K +$111K +39,933 +146%
B
100
Barings
North Carolina
$218K – – –
2 3
4
5 6

PDLI Hedge Fund Activity: Q3 2017 in Review

186 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in PDL BioPharma, Inc. (PDLI) for Q3 2017, worth a combined $466M — up 45% from $321M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new PDLI positions and 13 closed out — a net gain of 18 holders — while 63 added to existing stakes and 44 trimmed.

The largest buyer was Millennium Management, adding an estimated $8.55M. The largest seller was Citadel Advisors, cutting an estimated $9.56M.

  • 186 institutional investors held PDL BioPharma, Inc. (PDLI) as of Q3 2017, up from 171 in Q2 2017.
  • Funds reported $466M of PDL BioPharma, Inc. stock for Q3 2017, up 45% quarter-over-quarter.
  • 31 funds opened new PDL BioPharma, Inc. positions in Q3 2017 and 13 closed out, a net change of +18 holders.
  • The largest PDL BioPharma, Inc. buyer in Q3 2017 was Millennium Management, an estimated $8.55M added.
  • The largest PDL BioPharma, Inc. seller in Q3 2017 was Citadel Advisors, an estimated $9.56M sold.

Based on aggregated 13F filings for Q3 2017.